Hls Therapeutics Inc opened trading today at $5.10 and closed at $5.17. Intraday prices ranged from $5.05 to $5.43.

Shares advanced 3.19 percent from the previous day's close of $5.01.

During the day across North America, the TSX Composite closed -0.40% at 22110.11, the S&P 500 closed 0.74% at 5199.06, the Dow Jones Industrial Average closed -0.01% at 38459.08 and the Nasdaq Composite closed 1.68% at 16442.20.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

A total of 23,666 shares was traded during the session, with total trades of 79. On average, Hls Therapeutics Inc has traded 15,145 shares over the last 5-days and 10,232 year-to-date.

The TSX overall saw 788 price advancers against 4,485 declines and 84 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, the shares have shrunken -15.66 percent in 52 weeks, while they have boosted 30.89% this year.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $159.93 million on a float of 31,921 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Based on 5.00 analysts, Hls Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..